Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis. [PDF]
ABSTRACT Chenodeoxycholic acid (CDCA) is an essential drug for patients with rare metabolic disease cerebrotendinous xanthomatosis (CTX). To ensure continuation of treatment, the Amsterdam UMC hospital pharmacy developed pharmacy compounded CDCA capsules when the authorized CDCA capsules were no longer available for Dutch patients.
Bouwhuis N +9 more
europepmc +2 more sources
Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease
Ana Claudia Rodrigues de Cerqueira +2 more
doaj +2 more sources
Cerebrotendinous Xanthomatosis: A Rare Etiology of the "Hot-Cross Bun" Sign. [PDF]
Rani D, Singla D, Garg D.
europepmc +1 more source
Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis. [PDF]
Majait S +11 more
europepmc +1 more source
Cerebrotendinous xanthomatosis: A report of 3 cases
Katharine Saussy, MD +2 more
doaj +1 more source
Plasma sterol profiling in autism spectrum disorder: insights from cerebrotendinous xanthomatosis screening and beyond. [PDF]
Calisgan K +13 more
europepmc +1 more source
Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review. [PDF]
Ribeiro RM +14 more
europepmc +1 more source
Genomic Confluence: When Cerebrotendinous Xanthomatosis, Klinefelter Syndrome, and a BRCA2 Variant Intersect. [PDF]
Pachajoa H, Bonilla S, Nieva-Posso DA.
europepmc +1 more source
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients. [PDF]
Bouwhuis N, Jacobs BAW, Kemper EM.
europepmc +1 more source
Clinical and genetic analysis of a family with cerebrotendinous xanthomatosis. [PDF]
Guoliang Y +10 more
europepmc +1 more source

